Sobrevida de los pacientes con carcinoma renal avanzado tratados con interferón
Ares Valdés, Yolanda.
Arch. esp. urol. (Ed. impr.)
; 62(1): 17-21, ene.-feb. 2009. graf
Artículo en Español | IBECS (España) | ID: ibc-59997
Documentos relacionados
Adenoviral gene therapy for bladder cancer.
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.
Inhibiting cell-to-cell transmission to reach HDV cure: The importance of IFN-α.
You Can Breathe Easy: IFNλ Handles Flu without Triggering a Damaging Inflammatory Response.
Sequence Effect of Peptide-Based Materials on Delivering Interferon-α (IFN-α): A Molecular Dynamic Perspective.
Severe acute herpes virus type 2 primo-infection and its association with anti-type 1 interferon autoantibodies.
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort.
From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.
Structural linkage between ligand discrimination and receptor activation by type I interferons.
Construction of viral-based expression vectors for high-level production of human interferon alpha 2b in plants.